"Designing Growth Strategies is in our DNA"
Peripheral vascular intervention is a minimally invasive technique which is utilized to treat peripheral artery disease. Peripheral artery disease is caused due to building up plaque in arteries, which is also known as atherosclerosis. The important function of peripheral vascular intervention is to regularize blood flow to all parts of the body, including lower extremities to avoid amputations.
Certain causes such as smoking, diabetes, high cholesterol, and obesity are responsible for peripheral artery disease. According to National Heart, Lung and Blood Institute, an estimated 5.0% of population over 50 years suffer due to peripheral artery disease each year in the U.S. Also, according to Centres for Disease Control and Prevention, an estimated 8.5 million people in the U.S. are affected by peripheral artery disease, also 10.0-12.0% of the population is 50 years old.
To get information on various segments, share your queries with us
Benefits served by a peripheral vascular intervention such as enhanced safety, faster recovery, minimal hospital stays, and minimal procedural time are driving the global peripheral vascular intervention market. Also, the rising prevalence of peripheral artery disease is significantly driving the growth of the global peripheral vascular intervention market. Also, rise in certain risk factors such as obesity, smoking, high cholesterol, high blood pressure, and diabetes are prominently responsible for the rising prevalence of peripheral artery disease, which offers huge potential for mass adoption of peripheral vascular intervention procedures during the forecast period.
However, certain risk factors of peripheral vascular interventions such as allergic reaction, brain damage, infections, and strokes are restraining the global peripheral vascular intervention market.
Some of the key players present in the global peripheral vascular intervention market are Edwards Lifesciences Corporation, Cardinal Health, TERUMO CORPORATION, C. R. Bard, Inc., B. Braun Melsungen AG, Abbott, Boston Scientific Corporation, AngioScore Inc., Biotronik, Inc., Biosensors International Group, Ltd., Medtronic, and others.
By Procedure Type
By End User
· Ambulatory Surgery Centres
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
· Latin America (Brazil, Mexico, and Rest of Latin America)
· Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)
Among the segmentation of the global peripheral vascular intervention market, angioplasty from the procedure segment accounts for a larger share and is also anticipated to grow in the forecast period owing to its effective results in removal of coronary artery disease and also is a lower-risk option treatment.
Geographically, the global peripheral vascular intervention market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global peripheral vascular intervention market in 2017 owing to an aging population, rising prevalence of peripheral artery disease, and rise in risk factors for peripheral artery diseases such as obesity and diabetes. Combined with this, certain advantages such as minimally invasive surgeries, minimal procedural time, and improved effectiveness of peripheral vascular intervention due to stenting procedures are driving the global peripheral vascular intervention market. The Asia Pacific and Middle East & Africa hold huge potential for global peripheral vascular intervention market owing to the rising geriatric population, rise in smoking, and the growing number of people with high cholesterol. Growth in adoption of advanced techniques in the healthcare sector and prevalence of the disease offers huge potential for adoption of peripheral vascular intervention procedures during the forecast period.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm